Introduction
Angiotensin converting enzyme inhibitor (ACEI) has been reported to be especially effective in the treatment of hypertension related to disorders of the renin-angiotensin system. In hemodialysis (HD) patients, it is a well-known fact that the long-term use of captopril1,2) or enalapril3) aggravates the ane mia. We evaluated the incidence and severity of ane mia in HD patients who were receiving enalapril maleate, which is a long-acting ACEI.
Subjects and Methods
This study was conducted in 18 patients undergoing maintenance HD. They were 12 males and 6 females with the mean age of 49 ranging from 26 to 70 years. (Table) . We speculated that (1) enalapril-induced anemia was related to the suppression of Ep production, 
